Disclaimer :

The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.

SECTION 1.2

Description of the concentration

This Notification concerns the proposed acquisition by TPG Asia VI SF Pte. Ltd. (“TPG Asia”) and Hong Leong Healthcare Group Sdn Bhd (“Hong Leong” and, together with TPG Asia, the “Buyers”) of joint control over Columbia Asia Healthcare Pte. Ltd. (“CAHSG” and together with the Buyers, the “Parties”) (the “Proposed Transaction”).

Through the Proposed Transaction, HLT Healthcare Holdings Limited (“HLTHHL”), a newly established entity for the purpose of the Proposed Transaction in which each of TPG Asia and Hong Leong holds 50% of the share capital, will acquire sole control over CAHSG. HLTHHL will acquire 100% of the issued and paid-up share capital of CAHSG. The Buyers will have joint control over CAHSG through HLTHHL. The Proposed Transaction will take place by way of share purchase.

TPG Asia is registered in Singapore and part of TPG, a private investment firm that manages a family of funds that invest in a variety of companies through acquisitions and corporate restructurings. TPG is based in San Francisco, USA. TPG Asia forms part of the TPG Capital Asia platform, which focuses on Asian investments.

Hong Leong is registered in Malaysia and part of Hong Leong Group, a conglomerate based in Malaysia with diversified businesses in banking and financial services, manufacturing and distribution, property development and investments, hospitality, and leisure. Hong Leong was established on August 20, 2019 for the purpose of acquiring CAHSG and does not yet have any market activities. Hong Leong will focus on the healthcare sector.

CAHSG is the holding entity for the Columbia Asia Group, a private healthcare company founded in 1996 to provide accessible, affordable, and high-quality healthcare to meet the needs of the Asian population. CAHSG is based in Singapore and currently solely owned by International Columbia US, LLC, an investment fund based in the United States. CAHSG has 18 facilities across Asia: 12 hospitals in Malaysia, 2 hospitals and 1 clinic in Vietnam, and 3 hospitals in Indonesia. CAHSG currently also operates 11 hospitals in India, though those hospitals will be carved out from the transaction perimeter.

Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË

Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.